Galanthamine in Alzheimer??s Disease
- 1 February 1997
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 7 (2) , 89-97
- https://doi.org/10.2165/00023210-199707020-00001
Abstract
Galanthamine (galantamine), a tertiary alkaloid derived from the bulbs of the snowdrop and various Narcissus species, is a selective, centrally active and reversible inhibitor of acetylcholinesterase...Keywords
This publication has 34 references indexed in Scilit:
- Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.1994
- Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleepPsychiatry Research, 1994
- Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibitionClinical Pharmacology & Therapeutics, 1991
- Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humansEuropean Journal of Clinical Pharmacology, 1990
- A long-acting cholinesterase inhibitor reverses spatial memory deficits in micePharmacology Biochemistry and Behavior, 1988
- Unusual Aspects of Low Levels of Pseudocholinesterase in a Pregnant PatientAnesthesia & Analgesia, 1982
- ACTION OF CHOLINERGIC DRUGS IN EXPERIMENTAL AMNESIA1976
- Electroencephalographic and blood chemistry responses to galanthamine hydrobromide in epileptic volunteers.1973
- [Influence exerted by galanthamine on the acetylcholinesterase activity of various regions of the brain].1965
- [Nivaline (Galanthus nivalis) therapy in polimyelitis].1962